Asian-Pacific Alliance of Liver Disease, Beijing Report issue

Academic/Hospital Phase 4
Founded: Singapore Malaysia (1978)

Organization Overview

First Clinical Trial
2014
NCT02327663
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Asian Pacific Alliance of Liver Diseases, Beijing

Active Ingredients

Drugs in Phase 4 Trials (2)

emtricitabine (emtriva) (5 trials)

tenofovir (viread) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fibrosis (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Liver Cirrhosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 2